Feigal Ellen
SEC insider (Form 3/4/5 filer). CIK 0001758108. Director at Xencor Inc (XNCR) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in PASADENA, CA.
Companies Feigal Ellen has filed insider reports for
- Xencor Inc (XNCR): Director
- NextCure, Inc. (NXTC): Director
Feigal Ellen
CIK: 0001758108
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (42.9%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (57.1%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 18, 2026NXTC
NextCure, Inc.
AwardDirectStock Option (Right to Buy)
2.3K shares- - Jun 18, 2026XNCR
Xencor Inc
SaleDirect6.8K shares at avg. $13.06$89K - Jun 16, 2026XNCR
Xencor Inc
AwardDirect10.3K shares- - Jun 20, 2025NXTC
NextCure, Inc.
AwardDirectStock Option (Right to Buy)
18.7K shares- - Jun 16, 2025XNCR
Xencor Inc
SaleDirect3K shares at avg. $9.22$28K - Jun 12, 2025XNCR
Xencor Inc
AwardDirect13.7K shares- - Sep 27, 2024XNCR
Xencor Inc
SaleDirect2.5K shares at avg. $20.68$52K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  NXTC NextCure, Inc. | Award Stock Option (Right to Buy) | 2,340 | - | - | Direct |
| Jun 18, 2026 |  XNCR Xencor Inc | Sale | 6,843 | $13.06 | $89,370 | Direct |
| Jun 16, 2026 | XNCR Xencor Inc | Award | 10,302 | - | $0 | Direct |
| Jun 20, 2025 | NXTC NextCure, Inc. | Award Stock Option (Right to Buy) | 18,700 | - | - | Direct |
| Jun 16, 2025 | XNCR Xencor Inc | Sale | 2,993 | $9.22 | $27,595 | Direct |
| Jun 12, 2025 | XNCR Xencor Inc | Award | 13,686 | - | - | Direct |
| Sep 27, 2024 | XNCR Xencor Inc | Sale | 2,503 | $20.68 | $51,762 | Direct |
1-7 of 7 transactions